Imaging is never just imaging. A new generation of MR scanners requires new sequences and new coils. A new generation of CT scanners requires new protocols and techniques. The result of this added tweaking and tinkering is superior clinical images that take full advantage of the acquisition modality.
In this supplement to Diagnostic Imaging, we focus on the practical with an eye toward the possible. Dr. James Earls writes about his department's launch of a CT- and MR-based cardiac imaging service. We explore the scope of modern cardiovascular imaging with these two modalities. And we look at manufacturers and their collaborators working to make contrast agents keep up with the latest generation of CT scanners.
Between these two modalities, the face of cardiovascular imaging has shifted dramatically in recent years. The reemergence of two of radiology's traditional tools signals a renewed opportunity for the specialty to play a crucial role in the cardiovascular patient care process. With this supplement, Diagnostic Imaging continues its commitment to providing its readers with the information and perspective to strengthen the field.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.